ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Products and CMO Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9V9741
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Products and CMO Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pharmaceutical Products and CMO Market Research Report 2025

Code: QYRE-Auto-9V9741
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Catalent
Lonza
Aenova
Jubilant
Famar
Boehringer Ingelheim
AbbVie
Nipro Corp
Vetter
Sopharma
Recipharm
Thermo Fisher Scientific
Fareva
Baxter
Shandong Xinhua
Piramal
Mylan NV
Dr. Reddy's
Zhejiang Hisun
Zhejiang Huahai

Pharmaceutical Products and CMO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical Products and CMO Market

Pharmaceutical Products and CMO Market

The global market for Pharmaceutical Products and CMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Products and CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Products and CMO.
The Pharmaceutical Products and CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Products and CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Products and CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Products and CMO Market Report

Report Metric Details
Report Name Pharmaceutical Products and CMO Market
CAGR 5%
Segment by Type
  • Active Pharmaceutical Ingredient (API)
  • Finished Dosage Form (FDF)
Segment by Application
  • Large Enterprises
  • SMEs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Products and CMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Products and CMO Market report?

Ans: The main players in the Pharmaceutical Products and CMO Market are Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant

What are the Application segmentation covered in the Pharmaceutical Products and CMO Market report?

Ans: The Applications covered in the Pharmaceutical Products and CMO Market report are Large Enterprises, SMEs

What are the Type segmentation covered in the Pharmaceutical Products and CMO Market report?

Ans: The Types covered in the Pharmaceutical Products and CMO Market report are Active Pharmaceutical Ingredient (API), Finished Dosage Form (FDF)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredient (API)
1.2.3 Finished Dosage Form (FDF)
1.3 Market by Application
1.3.1 Global Pharmaceutical Products and CMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Large Enterprises
1.3.3 SMEs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Products and CMO Market Perspective (2020-2031)
2.2 Global Pharmaceutical Products and CMO Growth Trends by Region
2.2.1 Global Pharmaceutical Products and CMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Products and CMO Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Products and CMO Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Products and CMO Market Dynamics
2.3.1 Pharmaceutical Products and CMO Industry Trends
2.3.2 Pharmaceutical Products and CMO Market Drivers
2.3.3 Pharmaceutical Products and CMO Market Challenges
2.3.4 Pharmaceutical Products and CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Products and CMO Players by Revenue
3.1.1 Global Top Pharmaceutical Products and CMO Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Products and CMO Revenue
3.4 Global Pharmaceutical Products and CMO Market Concentration Ratio
3.4.1 Global Pharmaceutical Products and CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Products and CMO Revenue in 2024
3.5 Global Key Players of Pharmaceutical Products and CMO Head office and Area Served
3.6 Global Key Players of Pharmaceutical Products and CMO, Product and Application
3.7 Global Key Players of Pharmaceutical Products and CMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Products and CMO Breakdown Data by Type
4.1 Global Pharmaceutical Products and CMO Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Products and CMO Breakdown Data by Application
5.1 Global Pharmaceutical Products and CMO Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Products and CMO Market Size (2020-2031)
6.2 North America Pharmaceutical Products and CMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Products and CMO Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Products and CMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Products and CMO Market Size (2020-2031)
7.2 Europe Pharmaceutical Products and CMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Products and CMO Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Products and CMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Products and CMO Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Products and CMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Products and CMO Market Size (2020-2031)
9.2 Latin America Pharmaceutical Products and CMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Products and CMO Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Products and CMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Products and CMO Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Products and CMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Products and CMO Introduction
11.1.4 Catalent Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Products and CMO Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Products and CMO Introduction
11.3.4 Lonza Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Products and CMO Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Products and CMO Introduction
11.5.4 Fareva Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Details
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Products and CMO Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Details
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Products and CMO Introduction
11.7.4 Aenova Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Products and CMO Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Products and CMO Introduction
11.9.4 Baxter Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Details
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Products and CMO Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Details
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Products and CMO Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Details
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Products and CMO Introduction
11.12.4 Famar Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Details
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Products and CMO Introduction
11.13.4 Vetter Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Details
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Products and CMO Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Products and CMO Introduction
11.15.4 Piramal Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Products and CMO Introduction
11.16.4 Mylan Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Details
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Products and CMO Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Details
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Products and CMO Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Details
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Products and CMO Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Details
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Products and CMO Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Products and CMO Business (2020-2025)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Catalent
Lonza
Aenova
Jubilant
Famar
Boehringer Ingelheim
AbbVie
Nipro Corp
Vetter
Sopharma
Recipharm
Thermo Fisher Scientific
Fareva
Baxter
Shandong Xinhua
Piramal
Mylan NV
Dr. Reddy's
Zhejiang Hisun
Zhejiang Huahai
List of Tables
 Table 1. Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredient (API)
 Table 3. Key Players of Finished Dosage Form (FDF)
 Table 4. Global Pharmaceutical Products and CMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical Products and CMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Products and CMO Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical Products and CMO Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical Products and CMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical Products and CMO Market Share by Region (2026-2031)
 Table 10. Pharmaceutical Products and CMO Market Trends
 Table 11. Pharmaceutical Products and CMO Market Drivers
 Table 12. Pharmaceutical Products and CMO Market Challenges
 Table 13. Pharmaceutical Products and CMO Market Restraints
 Table 14. Global Pharmaceutical Products and CMO Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical Products and CMO Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical Products and CMO Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical Products and CMO Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical Products and CMO, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical Products and CMO, Product and Application
 Table 21. Global Key Players of Pharmaceutical Products and CMO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical Products and CMO Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical Products and CMO Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical Products and CMO Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical Products and CMO Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical Products and CMO Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical Products and CMO Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical Products and CMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical Products and CMO Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical Products and CMO Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Catalent Company Details
 Table 47. Catalent Business Overview
 Table 48. Catalent Pharmaceutical Products and CMO Product
 Table 49. Catalent Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 50. Catalent Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Pharmaceutical Products and CMO Product
 Table 54. Thermo Fisher Scientific Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Lonza Company Details
 Table 57. Lonza Business Overview
 Table 58. Lonza Pharmaceutical Products and CMO Product
 Table 59. Lonza Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 60. Lonza Recent Development
 Table 61. Boehringer Ingelheim Company Details
 Table 62. Boehringer Ingelheim Business Overview
 Table 63. Boehringer Ingelheim Pharmaceutical Products and CMO Product
 Table 64. Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 65. Boehringer Ingelheim Recent Development
 Table 66. Fareva Company Details
 Table 67. Fareva Business Overview
 Table 68. Fareva Pharmaceutical Products and CMO Product
 Table 69. Fareva Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 70. Fareva Recent Development
 Table 71. Recipharm Company Details
 Table 72. Recipharm Business Overview
 Table 73. Recipharm Pharmaceutical Products and CMO Product
 Table 74. Recipharm Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 75. Recipharm Recent Development
 Table 76. Aenova Company Details
 Table 77. Aenova Business Overview
 Table 78. Aenova Pharmaceutical Products and CMO Product
 Table 79. Aenova Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 80. Aenova Recent Development
 Table 81. AbbVie Company Details
 Table 82. AbbVie Business Overview
 Table 83. AbbVie Pharmaceutical Products and CMO Product
 Table 84. AbbVie Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 85. AbbVie Recent Development
 Table 86. Baxter Company Details
 Table 87. Baxter Business Overview
 Table 88. Baxter Pharmaceutical Products and CMO Product
 Table 89. Baxter Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 90. Baxter Recent Development
 Table 91. Nipro Corp Company Details
 Table 92. Nipro Corp Business Overview
 Table 93. Nipro Corp Pharmaceutical Products and CMO Product
 Table 94. Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 95. Nipro Corp Recent Development
 Table 96. Sopharma Company Details
 Table 97. Sopharma Business Overview
 Table 98. Sopharma Pharmaceutical Products and CMO Product
 Table 99. Sopharma Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 100. Sopharma Recent Development
 Table 101. Famar Company Details
 Table 102. Famar Business Overview
 Table 103. Famar Pharmaceutical Products and CMO Product
 Table 104. Famar Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 105. Famar Recent Development
 Table 106. Vetter Company Details
 Table 107. Vetter Business Overview
 Table 108. Vetter Pharmaceutical Products and CMO Product
 Table 109. Vetter Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 110. Vetter Recent Development
 Table 111. Shandong Xinhua Company Details
 Table 112. Shandong Xinhua Business Overview
 Table 113. Shandong Xinhua Pharmaceutical Products and CMO Product
 Table 114. Shandong Xinhua Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 115. Shandong Xinhua Recent Development
 Table 116. Piramal Company Details
 Table 117. Piramal Business Overview
 Table 118. Piramal Pharmaceutical Products and CMO Product
 Table 119. Piramal Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 120. Piramal Recent Development
 Table 121. Mylan Company Details
 Table 122. Mylan Business Overview
 Table 123. Mylan Pharmaceutical Products and CMO Product
 Table 124. Mylan Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 125. Mylan Recent Development
 Table 126. Dr. Reddy’s Company Details
 Table 127. Dr. Reddy’s Business Overview
 Table 128. Dr. Reddy’s Pharmaceutical Products and CMO Product
 Table 129. Dr. Reddy’s Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 130. Dr. Reddy’s Recent Development
 Table 131. Zhejiang Hisun Company Details
 Table 132. Zhejiang Hisun Business Overview
 Table 133. Zhejiang Hisun Pharmaceutical Products and CMO Product
 Table 134. Zhejiang Hisun Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 135. Zhejiang Hisun Recent Development
 Table 136. Zhejiang Huahai Company Details
 Table 137. Zhejiang Huahai Business Overview
 Table 138. Zhejiang Huahai Pharmaceutical Products and CMO Product
 Table 139. Zhejiang Huahai Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 140. Zhejiang Huahai Recent Development
 Table 141. Jubilant Company Details
 Table 142. Jubilant Business Overview
 Table 143. Jubilant Pharmaceutical Products and CMO Product
 Table 144. Jubilant Revenue in Pharmaceutical Products and CMO Business (2020-2025) & (US$ Million)
 Table 145. Jubilant Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Products and CMO Picture
 Figure 2. Global Pharmaceutical Products and CMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Products and CMO Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredient (API) Features
 Figure 5. Finished Dosage Form (FDF) Features
 Figure 6. Global Pharmaceutical Products and CMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Products and CMO Market Share by Application: 2024 VS 2031
 Figure 8. Large Enterprises Case Studies
 Figure 9. SMEs Case Studies
 Figure 10. Pharmaceutical Products and CMO Report Years Considered
 Figure 11. Global Pharmaceutical Products and CMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pharmaceutical Products and CMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmaceutical Products and CMO Market Share by Region: 2024 VS 2031
 Figure 14. Global Pharmaceutical Products and CMO Market Share by Players in 2024
 Figure 15. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Products and CMO Revenue in 2024
 Figure 17. North America Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pharmaceutical Products and CMO Market Share by Country (2020-2031)
 Figure 19. United States Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmaceutical Products and CMO Market Share by Country (2020-2031)
 Figure 23. Germany Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmaceutical Products and CMO Market Share by Region (2020-2031)
 Figure 31. China Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmaceutical Products and CMO Market Share by Country (2020-2031)
 Figure 39. Mexico Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmaceutical Products and CMO Market Share by Country (2020-2031)
 Figure 43. Turkey Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pharmaceutical Products and CMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Catalent Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 48. Lonza Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 50. Fareva Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 51. Recipharm Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 52. Aenova Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 53. AbbVie Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 54. Baxter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 55. Nipro Corp Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 56. Sopharma Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 57. Famar Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 58. Vetter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 59. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 60. Piramal Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 61. Mylan Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 62. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 63. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 64. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 65. Jubilant Revenue Growth Rate in Pharmaceutical Products and CMO Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Pharmaceutical CMO Services Market Research Report 2024
Global Biopharmaceutical CMO Services Market Research Report 2024
Global Contract Pharmaceutical Manufacturing Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Pharmaceutical Contract Manufacturing and Contract Market
Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical OEM and ODM Market Research Report 2024
Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical CMO CRO Market
Pharmaceutical Product Information Management System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Manufacturing Software Market Insights Forecast to 2030
Global Chemical Drug CMO Market Research Report 2024
Pharmaceutical Business Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma Contract Service Market Research Report 2025
Global Pharmaceutical Contract Filling Services Market Research Report 2025
Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Product Tester Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fill Finish Pharmaceutical Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions